Benzinga | Aug 11, 2020 04:20PM EDT

DiaMedica Therapeutics Q2 EPS $(0.17) Up From $(0.21) YoY

DiaMedica Therapeutics (NASDAQ:DMAC) reported quarterly losses of $(0.17) per share. This is a 19.05 percent increase over losses of $(0.21) per share from the same period last year.